Compugen (CGEN) Change in Cash (2009 - 2010)
Compugen (CGEN) reported Change in Cash of $3.0 million for Q4 2010, down 68.11% on a YoY basis from $9.5 million in Q4 2009, and up 139.57% sequentially from -$7.6 million in Q3 2010.
Compugen (CGEN) Change in Cash (2009 - 2010) Analysis & Trends
Compugen (CGEN) has 2 years of Change in Cash data on file, last reported at $3.0 million in Q4 2010.
- For the quarter ending Q4 2010, Change in Cash fell 68.11% year-over-year to $3.0 million; the trailing twelve-month figure through Dec 2010 stood at $4.0 million (changed N/A YoY), and the FY2025 full-year result was $72.4 million, up 1721.04% from the prior year.
- Change in Cash climbed to $3.0 million in Q4 2010, from -$7.6 million in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $9.5 million in Q4 2009 to a low of -$7.6 million in Q3 2010.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -22.03 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -2.44 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 243.78 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 417.10 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -153.10 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 57.19 Mn |
| 10 | Compugen | 215.59 Mn | 123.84 Mn | 352,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2010 | 3.02 Mn |
| Sep 30, 2010 | -7.64 Mn |
| Dec 31, 2009 | 9.48 Mn |
| Sep 30, 2009 | -827,000.00 |